Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06497283
NCT06497283
Recruiting
N/A

The Effect of Intraoperative Binaural Sound on Remifentanil Dose Required for General Anesthesia Using Remimazolam: a Randomized, Placebo-controlled Trial

Gangnam Severance Hospital1 site in 1 country72 target enrollmentJuly 12, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGeneral AnesthesiaProstate Cancer StageUterine Myoma

Overview

Phase
N/A
Intervention
Not specified
Conditions
General Anesthesia
Sponsor
Gangnam Severance Hospital
Enrollment
72
Locations
1
Primary Endpoint
Intraoperative remifentanil dose
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

It is important to decrease the remifentanil dose for general anesthesia maintenance when using remimazolam. We will evaluate the effect of binaural sound on general anesthesia maintenance with remimazolam infusion.

Registry
clinicaltrials.gov
Start Date
July 12, 2024
End Date
February 28, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hyun-Chang Kim

Associate Professor

Gangnam Severance Hospital

Eligibility Criteria

Inclusion Criteria

  • •Patients scheduled for general anesthesia
  • •Patients aged 20-60
  • •Patients with American Society of Anesthesiologist physical status classification 1-2
  • •Patients with ideal body weight 50-80 kg

Exclusion Criteria

  • •Patients with hearing disability
  • •Patients using opioids or sedatives in 1 week
  • •Patients who are dependent for alcoholics or drugs
  • •Patients with hypersensitivities to remimazolam or remifentanil
  • •Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia
  • •Patients with liver failure

Outcomes

Primary Outcomes

Intraoperative remifentanil dose

Time Frame: At anesthesia day 0

Intraoperative remifentanil dose will be measured at anesthesia day 0.

Secondary Outcomes

  • Intraoperative remimazolam dose(At anesthesia day 0)
  • Electroencephalography(At anesthesia day 0)
  • Pain score (0:no pain, 10:maximal pain)(At anesthesia day 0 and 1)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
N/A
Binaural Sound for Remimazolam InductionGeneral AnesthesiaProstate CancerUterine Myoma
NCT06099977Gangnam Severance Hospital72
Completed
Phase 4
Safety of Remifentanil InfusionUrinary Tract Problem
NCT01303627Diskapi Teaching and Research Hospital42
Completed
Phase 4
Role of LIDOCAINE IN Pediatric Cochlear Implant SurgeryAnesthesia
NCT04194294Wahba bakhet70
Completed
Phase 1
Effect of remifentanil based anesthesia on perioperative phagocytic function.patients who receives remifentanil or fentanyl based anesthesia
JPRN-UMIN000018331Department of anesthesiology, Musashikosugi Hospital Nippon Medical School40
Recruiting
N/A
Remifentanil effect during general anesthesia induction in hypertensive patientsDiseases of the circulatory system
KCT0002290Hanyang University Seoul Hospital222